Harrow Inc. HROW
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Harrow Inc. is an eyecare pharmaceutical company focused on discovering, developing, and commercializing ophthalmic pharmaceutical products for the U.S. market. The company operates through two primary business segments: The Branded segment, which includes FDA-approved ophthalmology pharmaceutical products such as IHEE…
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees373
TickerHROW
Statistics
Market Cap$1.53B
Revenue (TTM)$272.3M
Net Income-$5.1M
Net Margin-1.9%
EPS$-0.14
P/E-268.79
P/S5.22
P/B48.90
EV/EBITDA41.37
ROE-35.4%
Dividend Yield—
Price$41.10
Data: Twelve Data · Revenue = mcap / P/S